The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial

BACKGROUND: In nephrotic syndrome, the combination of furosemide and albumin infusion is a standard regimen to treat systemic edema. The efficacy of synthetic human atrial natriuretic peptide (hANP) for nephrotic syndrome to ameliorate the systemic edema and retain renal functions has not been fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanzaki, Motoko, Wada, Jun, Kikumoto, Yoko, Akagi, Shigeru, Nakao, Kazushi, Sugiyama, Hitoshi, Makino, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379862/
https://www.ncbi.nlm.nih.gov/pubmed/22723729
http://dx.doi.org/10.2147/IJNRD.S32191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379862/
https://www.ncbi.nlm.nih.gov/pubmed/22723729
http://dx.doi.org/10.2147/IJNRD.S32191

Ejemplares similares